The copper/zinc/calcium chelators, DP-109 and DP-460, were shown to be protective in ameliorating symptomatology related to ALS in a mouse transgenic model expressing G93A-mutated SOD1 [330]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.